Glenmark was founded with a vision to emerge as a leading integrated research-based global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules, both NCEs (New Chemical Entities) and NBEs (New Biological Entities). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory, and Dermatology.